Importance of P-cadherin, Beta-catenin, and Wnt5a/frizzled for Progression of Melanocytic Tumors and Prognosis in Cutaneous Melanoma
Overview
Affiliations
Purpose: It has been proposed that melanoma cells shift from E-cadherin to N-cadherin expression during tumor development, and recent gene profiling has shown increased expression of Wnt5a/Frizzled in aggressive melanomas possibly by interactions with beta-catenin. We therefore wanted to investigate the role of cadherin subtypes, beta-catenin, and Wnt5a/Frizzled in melanocytic tumors, with focus on prognosis in nodular melanomas.
Experimental Design: The immunohistochemical expression of E-cadherin, N-cadherin, P-cadherin, beta-catenin, and Wnt5a/Frizzled was examined using tissue microarrays of 312 melanocytic tumors.
Results: Cytoplasmic expression of P-cadherin was associated with increasing tumor thickness (P=0.005) and level of invasion (P=0.019), whereas membranous staining was associated with thinner (P=0.012) and more superficial (P=0.018) tumors. Increased cytoplasmic P-cadherin was associated with reduced survival (P=0.047). Lack of nuclear beta-catenin expression was related to increased tumor thickness (P=0.002) and poor patient survival in univariate (P=0.0072) and multivariate (P=0.004) analyses. Membranous expression of N-cadherin was significantly increased from primary tumors to metastatic lesions, whereas E-cadherin staining tended to be decreased. Wnt5a and its receptor Frizzled were highly coexpressed, and nuclear expression of both markers was significantly reduced from benign nevi to melanomas, with a shift from nuclear to cytoplasmic expression in malignant tumors. In addition, Wnt5a expression was significantly associated with nuclear beta-catenin expression.
Conclusions: Alterations in the expression and subcellular localization of cell adhesion markers are important in the development and progression of melanocytic tumors, and strong cytoplasmic P-cadherin expression and loss of nuclear beta-catenin staining were associated with aggressive melanoma behavior and reduced patient survival.
The tumor immune microenvironment in primary cutaneous melanoma.
Zilberg C, Ferguson A, Lyons J, Gupta R, Damian D Arch Dermatol Res. 2025; 317(1):273.
PMID: 39825956 PMC: 11742903. DOI: 10.1007/s00403-024-03758-8.
CDH3-AS1 antisense RNA enhances P-cadherin translation and acts as a tumor suppressor in melanoma.
Chadourne M, Griffith C, Xu X, Brennan E, Vera O, Mecozzi N bioRxiv. 2025; .
PMID: 39764055 PMC: 11703152. DOI: 10.1101/2024.12.26.630428.
Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y J Hematol Oncol. 2024; 17(1):46.
PMID: 38886806 PMC: 11184729. DOI: 10.1186/s13045-024-01563-4.
The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment.
Marrapodi R, Bellei B Cancers (Basel). 2024; 16(5).
PMID: 38473275 PMC: 10930874. DOI: 10.3390/cancers16050913.
Strope A, Phillips C, Khadgi S, Jenkinson S, Coschigano K, Malgor R Histol Histopathol. 2024; 39(6):715-727.
PMID: 38445662 DOI: 10.14670/HH-18-723.